ERJ Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept

ERJ Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept

As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marius Hoeper about the efficacy and safety of the activin signalling inhibitor sotatercept in a pooled analysis of PULSAR and STELLAR studies.

Jaksot(79)

ERJ February 2018: Effectiveness versus efficacy

ERJ February 2018: Effectiveness versus efficacy

As part of the February issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Martin Kolb interviews Jørgen Vestbo (The University of Manchester and Manch...

22 Helmi 201811min

ERJ January 2018: The RESPIRE trials

ERJ January 2018: The RESPIRE trials

As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy chief editor James Chalmers interviews the Anthony De Soyza (Newcastle University, ...

25 Tammi 201818min

ERJ December 2017: An interview with the new editors

ERJ December 2017: An interview with the new editors

As part of the December issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert interviews the incoming Chief Editor Martin Kolb and Deputy Chi...

21 Joulu 201714min

ERJ Nov 2017: ERS statement on the diagnosis and treatment of pulmonary disease caused by AATD

ERJ Nov 2017: ERS statement on the diagnosis and treatment of pulmonary disease caused by AATD

As part of the November issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the ERS statement on the diagnosis and treatment of p...

21 Joulu 20179min

ERJ October 2017: Lessons from IPF clinical trials over the past 25 years

ERJ October 2017: Lessons from IPF clinical trials over the past 25 years

As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the lessons learned from clinical trials in idiopathic...

26 Loka 201720min

ERJ September 2017: The hidden burden of severe asthma

ERJ September 2017: The hidden burden of severe asthma

As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the publication of the results of a survey of patien...

22 Syys 201711min

ERJ August 2017: Fevipiprant in allergic asthma not controlled by low-dose inhaled corticosteroids

ERJ August 2017: Fevipiprant in allergic asthma not controlled by low-dose inhaled corticosteroids

As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the publication of the results of a trial of fevipipran...

25 Elo 201715min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
tiedekulma-podcast
rss-poliisin-mieli
docemilia
rss-duodecim-lehti
utelias-mieli
filocast-filosofian-perusteet
rss-laakaripodi
rss-opeklubi
rss-lihavuudesta-podcast
rss-sosiopodi
sotataidon-ytimessa
mielipaivakirja
radio-antro
rss-radplus
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita